Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Katalysen Ventures is a venture capital firm based in Stockholm, Sweden, focused on turnaround investments. The firm collaborates closely with owner-led companies, investors, and domain experts to tackle complex challenges. They invest across multiple stages, including pre-seed to Series C, although specific fund size and assets under management are not disclosed.
Katalysen Ventures targets turnaround opportunities at attractive pre-turnaround valuations, aiming for exits within a 2–4 year timeframe. Their investment strategy emphasizes collaboration with entrepreneurs and experts to implement targeted solutions. They focus on sectors such as healthcare, fintech, SaaS, regtech, biotech, and commerce.
Notable investments by Katalysen Ventures include QuTEM, a platform for quality control in gene therapy; InvitePeople, a data-driven event management solution; S4DX, a digital pre-analytics platform for biological samples; Valega, a regulatory technology company for digital assets; and Alternativa, which simplifies ownership administration for Sweden's unlisted sector.
Submit your pitch through their form at katalysen.com.
Katalysen Ventures often co-invests alongside domain experts and entrepreneurs, focusing on turnaround opportunities rather than leading rounds independently.
The firm is open to follow-on investments, particularly if they align with their strategy of supporting ventures through operational challenges toward value realization.
Specific details about the fund size are not publicly disclosed, but Katalysen Ventures invests across various stages from pre-seed to Series C.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.